Effect of NADH on human immature ovum development

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057141

Enrollment

Unknown

Registered

2022-03-01

Start date

2022-02-25

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility

Interventions

Group 1:A certain concentration of NADH was added to the IVM medium

Group 2:A certain concentration of NADH was added to the culture medium at cleavage stage

Group 3:A certain concentration of NADH was added to the culture medium at blastocyst stage

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female patients with immature oocytes during the controlled ovarian hyperstimulation (COH) cycles.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
maturation rate;fertilization rate;cleavage rate;high-quality embryo rate;blastocyst rate;high-quality blastocyst rate;	—

Countries

China

Contacts

Public ContactZhang Zhiguo

The First Affiliated Hospital of Anhui Medical University

zzg_100@163.com+86 18155106683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026